Sign In
Buy NDRA
$4.70
+0.370 (+8.55%)
At Close: Jul 31, 2026
ENDRA Life Sciences Inc.'s (NDRA) CEO Francois Michelon on Q2 2020 Results - Earnings Call Transcript
07:21pm, Monday, 17'th Aug 2020
ENDRA Life Sciences Inc. (NASDAQ:NDRA) Q2 2020 Results Earnings Conference Call August 17, 2020, 4:30 PM ET Company Participants David Wells - Chief Financial Officer Francois Michelon - Chairman and
ENDRA Life Sciences (NDRA) Scheduled to Post Earnings on Friday
06:24am, Sunday, 09'th Aug 2020
ENDRA Life Sciences (NASDAQ:NDRA) is scheduled to be releasing its earnings data after the market closes on Friday, August 14th. ENDRA Life Sciences (NASDAQ:NDRA) last posted its quarterly earnings re
ANN ARBOR, MI / ACCESSWIRE / August 5, 2020 / ENDRA Life Sciences Inc. ("ENDRA") (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS™), today announced that its second qua
ENDRA Life Sciences to Host Second Quarter 2020 Financial Results Conference Call and Webcast on Monday, August 17, 2020 at 4:30 p.m. ET
08:40pm, Wednesday, 05'th Aug 2020
ANN ARBOR, MI / ACCESSWIRE / August 5, 2020 / ENDRA Life Sciences Inc.
AKKA: First-half 2020 Revenue
12:00am, Monday, 27'th Jul 2020
Regulatory News: AKKA (Paris:AKA) (BSE:AKA) (ISIN:FR0004180537): H1 2020 performance Low point in activity reached in May Solid performance of Data Re
ENDRA Life Sciences Mourns the Passing of Board Member Sanjiv Gambhir
08:00pm, Thursday, 23'rd Jul 2020
ANN ARBOR, MI / ACCESSWIRE / July 23, 2020 / ENDRA Life Sciences Inc.
ENDRA Life Sciences Granted Additional European Patent As Commercialization Begins | | IT Business Net
03:14pm, Wednesday, 22'nd Jul 2020
New grant expands coverage of key U.S. platform patent to Europe ANN ARBOR, MI / ACCESSWIRE / July 22, 2020 / ENDRA Life Sciences Inc. (''ENDRA'') (NASDAQ:NDRA), a pioneer of Therm
ENDRA Life Sciences Granted Additional European Patent As Commercialization Begins
01:00pm, Wednesday, 22'nd Jul 2020
New grant expands coverage of key U.
QIAGEN announces publication of Supplemental Reasoned Position Statement for proposed acquisition by Thermo Fisher
12:00am, Wednesday, 22'nd Jul 2020
QIAGEN announces publication of Supplemental Reasoned Position Statement for proposed acquisition by Thermo Fisher
Kronos Bio Appoints Barbara Kosacz, Chief Operating Officer and General Counsel
12:00am, Monday, 20'th Jul 2020
Kronos Bio, Inc., a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to trans
Emerging Market and Legal Trends in the Top Five Global Startup Ecosystems
11:15am, Friday, 17'th Jul 2020
The recently published Global Startup Ecosystem Report 2020 ranks the top global startup ecosystems by metrics including performance, funding, connectedness, talent, and knowledge to highlight the win
Zacks: Analysts Anticipate ENDRA Life Sciences Inc (NASDAQ:NDRA) to Announce -$0.21 EPS
05:50am, Tuesday, 14'th Jul 2020
Analysts forecast that ENDRA Life Sciences Inc (NASDAQ:NDRA) will post earnings of ($0.21) per share for the current quarter, according to Zacks Investment Research. Zero analysts have issued estimate
Model N Announces Date of Third Quarter Fiscal Year 2020 Financial Results
12:00am, Tuesday, 14'th Jul 2020
Model N, Inc. (NYSE: MODN), the leading provider of cloud revenue management solutions for Life Sciences and High Tech companies, plans to announce fi
ENDRA Life Sciences Expands Global Technology Protection With New Chinese Patents | | IT Business Net
03:16pm, Monday, 13'th Jul 2020
Grants further protect ENDRA's TAEUS® platform capabilities in key international market with over 400 million potential NAFLD patients ANN ARBOR, MI / ACCESSWIRE / July 13, 2020 / ENDRA Life Scie
